Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 5
1982 5
1983 7
1984 4
1985 3
1986 4
1987 2
1988 3
1989 2
1990 1
1991 2
1993 1
1994 3
1995 6
1996 6
1997 2
1998 7
1999 7
2000 2
2001 11
2002 7
2003 6
2004 7
2005 9
2006 6
2007 5
2008 9
2009 18
2010 24
2011 15
2012 14
2013 8
2014 14
2015 16
2016 14
2017 10
2018 6
2019 6
2020 4
2021 4
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

268 results
Results by year
Filters applied: . Clear all
Page 1
Fenofibric acid for hyperlipidemia.
Saurav A, Kaushik M, Mohiuddin SM. Saurav A, et al. Expert Opin Pharmacother. 2012 Apr;13(5):717-22. doi: 10.1517/14656566.2012.658774. Epub 2012 Mar 9. Expert Opin Pharmacother. 2012. PMID: 22404421 Review.
AREAS COVERED: This article reviews the role of fenofibric acid in the context of results from recent randomized trials on fenofibrate, including the ACCORD Trial. It discusses the current status of fenofibric acid in the management of dyslipidemia, es …
AREAS COVERED: This article reviews the role of fenofibric acid in the context of results from recent randomized trials on fen …
Fenofibric Acid (trilipix).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 May 4;51(1311):33-4. Med Lett Drugs Ther. 2009. PMID: 19417718 No abstract available.
In vitro metabolism of fenofibric acid by carbonyl reducing enzymes.
Malátková P, Kanavi M, Nobilis M, Wsól V. Malátková P, et al. Chem Biol Interact. 2016 Oct 25;258:153-8. doi: 10.1016/j.cbi.2016.09.001. Epub 2016 Sep 4. Chem Biol Interact. 2016. PMID: 27599626
Fenofibric acid is a hypolipidemic drug that is used as an active ingredient per se or is administered in the form of fenofibrate that releases fenofibric acid after absorption. The metabolism of fenofibric acid is mediated primarily by g …
Fenofibric acid is a hypolipidemic drug that is used as an active ingredient per se or is administered in the form of fenofibr …
Lipid-lowering drugs.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.
Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia.
Yang LP, Keating GM. Yang LP, et al. Am J Cardiovasc Drugs. 2009;9(6):401-9. doi: 10.2165/11203920-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 19929038
Fenofibric acid activates peroxisome proliferator-activated receptor alpha to modify fatty acid and lipid metabolism. ...Once-daily fenofibric acid 135 mg plus a statin was generally as well tolerated as monotherapy with fenofibric aci …
Fenofibric acid activates peroxisome proliferator-activated receptor alpha to modify fatty acid and lipid metabolism. . …
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Wiggins BS, Saseen JJ, Page RL 2nd, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology. Wiggins BS, et al. Circulation. 2016 Nov 22;134(21):e468-e495. doi: 10.1161/CIR.0000000000000456. Epub 2016 Oct 17. Circulation. 2016. PMID: 27754879 Review. No abstract available.
Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans.
Zhu T, Ansquer JC, Kelly MT, Sleep DJ, Pradhan RS. Zhu T, et al. J Clin Pharmacol. 2010 Aug;50(8):914-21. doi: 10.1177/0091270009354995. Epub 2010 Feb 9. J Clin Pharmacol. 2010. PMID: 20145261 Clinical Trial.
This study compared the gastrointestinal (GI) absorption characteristics and absolute bioavailability of fenofibric acid and fenofibrate (which is converted to fenofibric acid in vivo) in healthy volunteers. ...Serial blood samples were collected for 1 …
This study compared the gastrointestinal (GI) absorption characteristics and absolute bioavailability of fenofibric acid and f …
Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs.
Kim KS, Jin SG, Mustapha O, Yousaf AM, Kim DW, Kim YH, Kim JO, Yong CS, Woo JS, Choi HG. Kim KS, et al. Int J Pharm. 2015 Jul 25;490(1-2):273-80. doi: 10.1016/j.ijpharm.2015.05.059. Epub 2015 May 27. Int J Pharm. 2015. PMID: 26024820
The objective of this study was to develop a novel fenofibric acid-loaded controlled release pellet showing enhanced, or equivalent to, bioavailability compared with two commercially available products containing fenofibrate or choline fenofibrate. ...Thus, this pel …
The objective of this study was to develop a novel fenofibric acid-loaded controlled release pellet showing enhanced, or equiv …
Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate.
Honda A, Kamata S, Akahane M, Machida Y, Uchii K, Shiiyama Y, Habu Y, Miyawaki S, Kaneko C, Oyama T, Ishii I. Honda A, et al. Int J Mol Sci. 2022 Apr 25;23(9):4726. doi: 10.3390/ijms23094726. Int J Mol Sci. 2022. PMID: 35563117 Free PMC article.
Although the efficacy and efficiency highly varied between agonists, assay types, and PPAR subtypes, the three fibrates, except fenofibric acid that did not affect PPARdelta-mediated transactivation and coactivator recruitment, activated all PPAR subtypes in those a …
Although the efficacy and efficiency highly varied between agonists, assay types, and PPAR subtypes, the three fibrates, except fenofibri …
Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry.
Wei X, Li P, Liu M, Du Y, Wang M, Zhang J, Wang J, Liu H, Liu X. Wei X, et al. Biomed Chromatogr. 2017 Apr;31(4). doi: 10.1002/bmc.3832. Epub 2016 Oct 10. Biomed Chromatogr. 2017. PMID: 27594083
Choline fenofibrate is the choline salt of fenofibric acid, which releases free fenofibric acid in the gastrointestinal tract. ...This method successfully supported the determination of fenofibric acid and choline fenofibrate. The absolut …
Choline fenofibrate is the choline salt of fenofibric acid, which releases free fenofibric acid in the gastroint …
268 results